Navigation Links
USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
Date:12/11/2008

he financial support from HHS enables us to continue our Pandemic Flu program with full speed in 2009. The progress of this program is also an important endorsement of the ability of our patch technology to enhance the immune response, when combining it with an injected vaccine."

About Pandemic Influenza

Three influenza pandemics have occurred in the 20th century leading to the death of more than 50 million people globally. By U.S. government estimates, pandemic influenza has a greater potential to cause deaths and illnesses than virtually any other natural health threat. Signs of a pandemic influenza have emerged in Southeast Asia, as lethal infections of poultry and humans with avian influenza virus continue. The current virus is now endemic in bird populations, having spread to more than 40 countries and causing the deaths of hundreds of millions of birds. Furthermore, the World Health Organization reports that the number of avian flu cases in humans has reached more than 370 cases in 14 countries.

Development of Pandemic Influenza Vaccines

Intercell believes that its vaccine patch (immunostimulant patch) has the potential for the development of improved influenza vaccines, especially in the field of pandemic influenza. Preclinical studies and the Phase I/II clinical study results using the patch with H5N1 vaccine suggest that this strategy may be used for other applications where improved immunogenicity, decreased antigen doses, or fewer immunization visits are desired.

About Intercell AG

Intercell AG is a growing biotechnology company which focuses on the design and development of novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical need. The Company develops antigens and adjuvants which are derived from its proprietary technology platforms and has in-house GMP manufacturing capabilities. Based on these
'/>"/>

SOURCE Intercell AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
2. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
5. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
6. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
7. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
8. California Stem Cell Agency Exaggerated Its Role in Funding Key Research
9. Continued Funding to Help Advance Exciting Moment in Diabetes Research
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  Zacks.com announces the list of stocks ... Equity Research analysts discuss the latest news and events ... in the blog include Actavis, Inc.,s (NYSE: ACT ... (NYSE: TOT ), Petrobras (NYSE: PBR ) ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) Get ...
(Date:5/21/2013)... SANTA CLARA, Calif. , May 21, ... a game-changing embedded-ultrasound platform, today announced the ... Toolkit that allows complete network-based communications with ... demonstrate its latest embedded-ultrasound technology, including this ... Sao Paulo, Brazil ...
(Date:5/21/2013)... N.Y. , May 21, 2013  Vasomedical, Inc. (OTC ... in the design, manufacture and sale of medical devices and ... that Dr. Jun Ma , President and ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
... May 5 Reportlinker.com announces that a new market research report is available in its catalogue: , ... Market , , , ... This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of ... General Anesthesia , , , ...
... ,, SHENZHEN, China , ... Inc.,(Nasdaq: WWIN ; "Winner Medical" or the "Company"), ... PurCotton(R) materials,for the medical and consumer products industries, today ... quarter of fiscal year 2010 on, Tuesday, May 11 ...
Cached Medicine Technology:Reportlinker Adds The World Anesthesia Drug Market 2Reportlinker Adds The World Anesthesia Drug Market 3Reportlinker Adds The World Anesthesia Drug Market 4Reportlinker Adds The World Anesthesia Drug Market 5Reportlinker Adds The World Anesthesia Drug Market 6Reportlinker Adds The World Anesthesia Drug Market 7Reportlinker Adds The World Anesthesia Drug Market 8Reportlinker Adds The World Anesthesia Drug Market 9Reportlinker Adds The World Anesthesia Drug Market 10Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 2Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 3Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 4
(Date:5/21/2013)... By Amy Norton HealthDay Reporter , , TUESDAY, ... alterations in two genes may be at increased risk ... study suggests. The researchers hope they can use ... help spot pregnant women who are vulnerable to postpartum ... Their study, reported in the May 21 issue ...
(Date:5/21/2013)... 21, 2013 The Special Olympics Missouri State ... from across the state to Columbia. This state-level event takes ... of Missouri and Columbia College, and at Hickman High School ... Games officially kick off at 7:30 p.m. Friday, May 30 ... Go Wild! theme, the Parade of Athletes, the culmination of ...
(Date:5/21/2013)... Not all treatments are effective when it ... Disorder (BPD) and addiction. Dialectical Behavior Therapy (DBT) is ... the treatment of both BPD and substance abuse. , ... director of Clearview Women’s Center for Borderline Personality ... of the West Coast Symposium on Addictive Disorders (WCSAD), ...
(Date:5/21/2013)... May 21, 2013 Children with autism showed significant ... home using everyday items such as scents, spoons and ... that a treatment known as environmental enrichment led to ... 3 and 12. Results appear online in Behavioral ... Leon randomly assigned 28 boys to one of two ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 STAR ... center for children with sensory challenges and the ... in research, education and advocacy of Sensory Processing Disorder ... SPD: Strategies to Improve Quality of Life, a two-hour ... Temple University, Pennsylvania. , Learn a method that ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3Health News:Enrichment therapy effective among children with autism, UCI study finds 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3
... to various health complications in newborns, says a study//. ... foods like nuts, vegetable oil and broccoli. Earlier research ... C, could help protect against miscarriage and pre-eclampsia. ... study at St. Thomas' Hospital in London, warned that ...
... who had heart attack, and stopped taking antiplatelet drugs within ... times more risk of death than others. ,"An ... their antiplatelet medication within the first 30 days of receiving ... drugs at the time of hospital discharge and recommendations are ...
... from Florida have stated on Tuesday that a short course ... with rotavirus, //which kills half a million youngsters in mainly ... by the privately owned U.S. Company, Romark Laboratories under the ... problem in just over 30 hours in young children with ...
... it was found that hydrogenated fat or processed fat resulted ... biscuits to cut manufacturing costs of foods and increase their ... and ready meals. People put on weight especially in the ... by heating natural fats to 250C and then bubbling hydrogen ...
... glucose metabolism, which occurs when the body has difficulty ... among patients //with chronic nerve dysfunction of unknown cause ... risk factor for the condition, according to a study ... 2006 print issue of Archives of Neurology, one of ...
... of Assam Tarun Gogoi had today undergone treatment at the ... ,Sources close to him explained that Gogoi, who ... Europe and Canada, was taken to AIIMS as he had ... Gogoi at the AIIMS said that he was suffering from ...
Cached Medicine News:Health News:Risk Of Death Increases With Sudden Withdrawal Of Medications 2Health News:Risk Of Death Increases With Sudden Withdrawal Of Medications 3Health News:Hydrogenated Fat Pts Weight around the Abdomen 2Health News:Abnormal Glucose Metabolism May Contribute to Chronic Nerve Disorder 2
Reusable Components Compatible with VERSASTEP™ Reposable Access System....
The VersaStep™ 5 mm and VersaStep™ PLUS Reposable system components for creating each access port are supplied in separate packages....
... VERSASTEP™ Plus Long Instrument for ... ,The VERSASTEP™ Plus Long Instrument ... a unique endoscopic entry device ... procedures. It is used to ...
... Step™ and Mini Step™ device components are supplied ... Single Use System is supplied sterile in 2/3, ... in various configurations and combinations. They are used ... needle and the Step™ radially Expandable Sleeve. The ...
Medicine Products: